Prostate Cancer Research Foundation is a non-profit organization, established by late Peter Grimm DO, one of the founders of modern Prostate Brachytherapy. The content is this web site is an updated information based on 2012 BJU peer review publication on comparative analysis of PSA recurrence free survival in prostate cancer patients, in all risk groups treated by any radical therapy. The information form this website may help with understanding of expected long term treatment result for various prostate cancer risk groups and various potentially curative treatments.
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.